Masayuki Waki

Seirei Hamamatsu General Hospital

Papers

1

Total Citations

1

H-Index

1

About

Dr. Masayuki Waki is a urologic surgeon and researcher whose work focuses on the diagnosis and surgical management of rare and complex prostate malignancies. His major contributions center on the application of advanced imaging, particularly PET-CT, to identify atypical prostate cancers that evade standard detection due to normal PSA levels. In his landmark case study, Dr. Waki demonstrated the effective diagnosis and treatment of a patient with primary squamous cell carcinoma of the prostate—a disease accounting for less than 1% of prostate cancers—using robot-assisted radical prostatectomy. This work, published in 2025, has already garnered 1 citation and highlights his expertise in navigating diagnostic challenges where conventional biomarkers fail. Dr. Waki’s research underscores the critical role of multimodal imaging in urologic oncology and advances the surgical frontier for rare prostate histologies. His findings offer a valuable roadmap for clinicians encountering similar diagnostic dilemmas, reinforcing the importance of tailored, technology-driven approaches in modern urology.

Research Focus

Key Achievements

1
H-Index
1
Papers
1
Total Citations
1
Avg Citations/Paper
🏆 Most Cited Paper
Locally Advanced Prostate Squamous Cell Carcinoma Diagnosed Using <scp>PET</scp>‐<scp>CT</scp> and Treated With Robot‐Assisted Radical Prostatectomy
1 citations · 2025
📈 Most Prolific Year: 2025 (1 Papers)
🤝 Key Collaborators: 9
🏛 Institutions: Seirei Hamamatsu General Hospital

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago